about
X-linked acrogigantism syndrome: clinical profile and therapeutic responsesPTX3 plays a key role in the organization of the cumulus oophorus extracellular matrix and in in vivo fertilization.Potent constitutive cyclic AMP-generating activity of XLαs implicates this imprinted GNAS product in the pathogenesis of McCune-Albright syndrome and fibrous dysplasia of bone.European guidance for the molecular diagnosis of pseudohypoparathyroidism not caused by point genetic variants at GNAS: an EQA study.Pathogenesis of prolactinomas.Mechanisms of disease: Mutations of G proteins and G-protein-coupled receptors in endocrine diseases.Hormonal signaling and pituitary adenomas.Genetic abnormalities of somatostatin receptors in pituitary tumors.Protein kinase A regulatory subunits in human adipose tissue: decreased R2B expression and activity in adipocytes from obese subjectsCell-specific regulation of PTX3 by glucocorticoid hormones in hematopoietic and nonhematopoietic cellsGNAS imprinting and pituitary tumors.Clinical review: Pseudohypoparathyroidism: diagnosis and treatment.cAMP pathway and pituitary tumorigenesis.GNAS epigenetic defects and pseudohypoparathyroidism: time for a new classification?Deciphering the specific role of G(αi/o) isoforms: functional selective oxytocin ligands and somatostatin SST5 receptor mutants.cAMP in the pituitary: an old messenger for multiple signals.Filamin A in somatostatin and dopamine receptor regulation in pituitary and the role of cAMP/PKA dependent phosphorylation.Specific roles of G(i) protein family members revealed by dissecting SST5 coupling in human pituitary cells.Patients with macroprolactinaemia: clinical and radiological features.Pseudohypoparathyroidism type Ib in 2015.Activation of the dopamine receptor type-2 (DRD2) promoter by 9-cis retinoic acid in a cellular model of Cushing's disease mediates the inhibition of cell proliferation and ACTH secretion without a complete corticotroph-to-melanotroph transdifferentFilamin A (FLNA) plays an essential role in somatostatin receptor 2 (SST2) signaling and stabilization after agonist stimulation in human and rat somatotroph tumor cells.Effect of 9-cis retinoic acid on dopamine D2 receptor expression in pituitary adenoma cells.Hypothalamic-Pituitary Axis in Non-Functioning Pituitary Adenomas: Focus on the Prevalence of Isolated Central Hypoadrenalism.Screening for ACTH-dependent hypercortisolism in patients affected with pituitary incidentaloma.Role of IGF1-(CA)19 promoter microsatellite in the clinical presentation of acromegaly.Activity and function of the nuclear factor kappaB pathway in human parathyroid tumors.Octreotide promotes apoptosis in human somatotroph tumor cells by activating somatostatin receptor type 2.An alternate translation initiation site circumvents an amino-terminal DAX1 nonsense mutation leading to a mild form of X-linked adrenal hypoplasia congenita.Growth hormone-releasing hormone resistance in pseudohypoparathyroidism type ia: new evidence for imprinting of the Gs alpha gene.Filamin-A is essential for dopamine d2 receptor expression and signaling in tumorous lactotrophs.Cyclic adenosine 3'-5'-monophosphate (cAMP) exerts proliferative and anti-proliferative effects in pituitary cells of different types by activating both cAMP-dependent protein kinase A (PKA) and exchange proteins directly activated by cAMP (Epac).Role of UGT1A1 and ADH gene polymorphisms in pegvisomant-induced liver toxicity in acromegalic patients.Pseudohypoparathyroidism type Ia: a novel GNAS mutation in a Brazilian boy presenting with an early primary hypothyroidism.The dopamine-somatostatin chimeric compound BIM-23A760 exerts antiproliferative and cytotoxic effects in human non-functioning pituitary tumors by activating ERK1/2 and p38 pathways.Quantitative analysis of methylation defects and correlation with clinical characteristics in patients with pseudohypoparathyroidism type I and GNAS epigenetic alterations.GH response to oral glucose tolerance test: a comparison between patients with acromegaly and other pituitary disorders.Parental origin of Gsalpha mutations in the McCune-Albright syndrome and in isolated endocrine tumors.HESX1 expression in human normal pituitaries and pituitary adenomas.Double pituitary and conserved function in an adult patient with neurofibromatosis type 1.
P50
Q30370618-815AA558-5A29-4941-BD04-2393D624679CQ34302929-595A9844-49CB-4087-978A-743DD53125C6Q34493975-5509F8B9-EF6E-43E5-BF2D-EBC69BBD0A41Q36338177-36751DF5-DE48-4D13-A60B-9A198CF0BB15Q36367489-7B7A18FB-F825-4EFD-957F-C0B301EB6299Q36672702-DFA6012E-FA7A-4B29-9064-A9AB306B4511Q36751727-77A7D16A-C21B-4DC1-8427-6540BA87C615Q36959247-F0F9CDEA-5360-4B4E-B844-207BF5C3F4BDQ37105314-0F66CF1D-1A3C-488E-B002-791346124BBAQ37142550-494CF7D5-DA2C-4880-B36A-256999780483Q37732570-0BAFF939-E2AB-4474-9BF8-44CB97C9F21FQ37911739-66F8143F-7AA2-4396-ABED-421CCE0D49AAQ38004751-8BB3B3B2-9051-49C3-948C-FF26D9C7D174Q38016797-B0561EA5-A228-484D-AAFF-0933165108ABQ38077225-4FDB2BA9-871F-4440-B4CD-AD2C24C991E0Q38139345-0284C968-046D-4A71-95D2-AAF454859D5EQ38234618-7C02CF23-045A-4DBE-BAC4-DAB3E115E4FFQ38319765-0479FB99-1DA8-43C1-99FF-E73C1D64D122Q38431837-6F161D55-4610-4E4B-997A-39EFEE991DC1Q38441216-5BAA4279-B396-4F95-85CD-3451E402641EQ38985205-A79BA441-29D0-4952-9274-67D3AC25364EQ38994959-8540007E-ADE5-4D1A-9848-D277947ED5BCQ39998318-8F39ED8A-E9F4-4E41-9D65-0BEF3639E34CQ40997563-8B2313F9-6AD8-42A2-805A-9B5A9DABEEB9Q41343280-439E84E2-DECA-4319-8E14-380875C091C6Q42468096-FB4D9EA2-707F-4613-88A9-F54FF00303C4Q42487214-396D688E-F611-4AA3-AF02-4BD5551D78CFQ42500942-3DBB6CD9-AC45-4C24-A097-40603182DBD9Q44273327-23492150-73FC-4491-A1F8-07FCB3D2DACAQ44582434-C7B80F2A-B69F-4E6E-BBA3-DE662175A634Q45359596-4F8491B1-27C2-4D1C-A382-478A2B46AFA1Q45387297-28823B58-8881-4622-9EF7-9A957DDC6308Q45393369-DF9A1858-4FDB-4ABE-9890-7F1113F60113Q45829719-A431422B-BD46-432F-96E5-971773349876Q45924750-9889C47B-2C7C-466A-BBE1-B002CCE3B9ACQ46599513-119AD52B-5FF4-43ED-8744-D251FAA3AC73Q46778593-0F0545E8-4038-4E9D-923C-F899F59FBB2DQ47386442-37DD16E6-57C5-415F-89D6-A1DCDDA8F306Q48687102-9E3E95B5-3789-4A47-8325-E76D0FCABF9EQ49082754-C76F55B8-118B-43A4-A3C2-5FEFA4CD3B99
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Giovanna Mantovani
@ast
Giovanna Mantovani
@en
Giovanna Mantovani
@es
Giovanna Mantovani
@nl
Giovanna Mantovani
@sl
type
label
Giovanna Mantovani
@ast
Giovanna Mantovani
@en
Giovanna Mantovani
@es
Giovanna Mantovani
@nl
Giovanna Mantovani
@sl
prefLabel
Giovanna Mantovani
@ast
Giovanna Mantovani
@en
Giovanna Mantovani
@es
Giovanna Mantovani
@nl
Giovanna Mantovani
@sl
P106
P1153
13805129100
P21
P31
P496
0000-0002-9065-3886